Indian pharmaceutical giant Wockhardt is currently in merger talks. The company, known for its diverse selection of generic and branded drugs, has been facing difficulties in recent years. Sources close to the transaction suggest that Wockhardt is {attracting interest from|receiving bids from both domestic and international companies. A final decis